Alyeska Investment Group, L.P. Ptc Therapeutics, Inc. Transaction History

Alyeska Investment Group, L.P.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$40.4 - $59.1 $8.08 Million - $11.8 Million	200,000 Added 133.33%	350,000 $14.2 Million
Q1 2023 May 15, 2023	BUY	$38.16 - $48.86 $5.72 Million - $7.33 Million	150,000 New	150,000 $7.27 Million
Q1 2018 May 15, 2018	BUY	$17.46 - $32.59 $523,800 - $977,700	30,000 New	30,000 $812,000

221

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $3.31B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of Alyeska Investment Group, L.P., based on Form 13F filings with the SEC.

Stay updated on Alyeska Investment Group, L.P. with notifications on news.